อายุรศาสตร์ จุฬาลงกรณ์ Chulalongkorn Internal Medicine
Cumedicine Board => CU Medicine Public Board => Topic started by: Wanla on August 04, 2012, 12:47:35 PM
-
Journal Session: Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
Rotating resident: Pattaramon S.
Fellow: Sunee C.
Rm 117 Internal Medicine Bldg
09:00-10:00
For more, please visit www.idchula.org :)